← All Sponsors

SPONSOR

City of Hope Medical Center

Total Trials

21

Recruiting

21

Phases

Phase 1, Phase 2, EARLY_Phase 1, Phase 2, Phase 1

Conditions studied: CRC (Colorectal Cancer)Mantle Cell Lymphoma HIV-1 Folliculotropic Mycosis Fungoides Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Sezary Syndrome Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8 Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8

Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC

CRC (Colorectal Cancer)

NCT03523975 Phase 1, Phase 2

Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma

NCT06252402 EARLY_Phase 1

CMV-specific HIV-CAR T Cells as Immunotherapy for HIV/AIDS

NCT04930653 Phase 2

Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

Folliculotropic Mycosis Fungoides

NCT06195891 Phase 1

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Acute Lymphoblastic Leukemia

NCT06575296 Phase 1

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

NCT04887805 Phase 2

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Advanced Pancreatic Ductal Adenocarcinoma

NCT06572605 Phase 1, Phase 2

External Beam Radiation Therapy in Combination With Talquetamab for the Treatment of Multiple Myeloma Patients With Extramedullary Disease

Extramedullary Disease in Multiple Myeloma

NCT05869682 Phase 2

Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy

Advanced Prostate Carcinoma

NCT05722288 Phase 2

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Localized Prostate Carcinoma

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

Pancreatic Ductal Adenocarcinoma

[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer

Prostate Carcinoma

Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules

Thyroid Gland Carcinoma

NCT04484012 Phase 2

Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma

Early Onset Colorectal Cancer Detection

Colorectal Cancer

NCT05432635 Phase 1

Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lymphoma

B-Cell Non-Hodgkin Lymphoma

NCT05672368 Phase 2

The da Vinci Single Port Robotic System for Use in Abdominal and Pelvic Surgical Procedures

Disease or Disorder

NCT06454383 Phase 1

Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer

Advanced Pancreatic Adenocarcinoma

Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy

Prostate Carcinoma

NCT06538389 Phase 2

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

Anatomic Stage 0 Breast Cancer AJCC v8

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Cutaneous Lymphoma